Form 8-K - Current report:
SEC Accession No. 0001213900-20-020390
Filing Date
2020-08-05
Accepted
2020-08-05 16:30:47
Documents
1
Period of Report
2020-08-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea125058-8k_actinium.htm 8-K 16867
  Complete submission text file 0001213900-20-020390.txt   17995
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 201078055
SIC: 2834 Pharmaceutical Preparations